These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS). Morris G; Maes M Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418 [TBL] [Abstract][Full Text] [Related]
47. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID). Corbitt M; Eaton-Fitch N; Staines D; Cabanas H; Marshall-Gradisnik S BMC Neurol; 2019 Aug; 19(1):207. PubMed ID: 31445522 [TBL] [Abstract][Full Text] [Related]
48. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors. Wirth K; Scheibenbogen C Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028 [TBL] [Abstract][Full Text] [Related]
49. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E Neuro Endocrinol Lett; 2009; 30(4):470-6. PubMed ID: 20010505 [TBL] [Abstract][Full Text] [Related]
50. IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression. Maes M; Mihaylova I; Kubera M; Leunis JC; Twisk FN; Geffard M Metab Brain Dis; 2012 Dec; 27(4):415-23. PubMed ID: 22614823 [TBL] [Abstract][Full Text] [Related]
51. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery. Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J Front Immunol; 2020; 11():582330. PubMed ID: 33329554 [TBL] [Abstract][Full Text] [Related]
52. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469 [TBL] [Abstract][Full Text] [Related]
53. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Johnston S; Staines D; Klein A; Marshall-Gradisnik S BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969 [TBL] [Abstract][Full Text] [Related]
54. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus? Hatziagelaki E; Adamaki M; Tsilioni I; Dimitriadis G; Theoharides TC J Pharmacol Exp Ther; 2018 Oct; 367(1):155-167. PubMed ID: 30076265 [TBL] [Abstract][Full Text] [Related]
55. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from? Toogood PL; Clauw DJ; Phadke S; Hoffman D Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750 [TBL] [Abstract][Full Text] [Related]
56. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Rivas JL; Palencia T; Fernández G; García M Front Immunol; 2018; 9():1028. PubMed ID: 29867995 [TBL] [Abstract][Full Text] [Related]
57. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study. Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133 [TBL] [Abstract][Full Text] [Related]
58. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta. Nijs J; Van Oosterwijck J; Meeus M; Lambrecht L; Metzger K; Frémont M; Paul L J Intern Med; 2010 Apr; 267(4):418-35. PubMed ID: 20433584 [TBL] [Abstract][Full Text] [Related]
59. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME. Daniels J; Brigden A; Kacorova A Psychol Psychother; 2017 Sep; 90(3):502-509. PubMed ID: 28244209 [TBL] [Abstract][Full Text] [Related]
60. Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test. Tomas C; Lodge TA; Potter M; Elson JL; Newton JL; Morten KJ Sci Rep; 2019 Aug; 9(1):11464. PubMed ID: 31391529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]